Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies

Clicks: 113
ID: 269940
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #76 of 95 articles by views in acta neuropathologica communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Definitive diagnosis of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) relies on postmortem finding of disease-associated alpha-synuclein (αSyn[D] ) as misfolded protein aggregates in the central nervous system (CNS). The ...
Reference Key
chen2021actastreamlined Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Connor Bargar, Wen Wang, Steven A. Gunzler, Alexandra LeFevre, Zerui Wang, Alan J. Lerner, Neena Singh, Curtis Tatsuoka, Brian Appleby, Xiongwei Zhu, Rong Xu, Vahram Haroutunian, Wen-Quan Zou, Jiyan Ma, Shu G. Chen;Connor Bargar;Wen Wang;Steven A. Gunzler;Alexandra LeFevre;Zerui Wang;Alan J. Lerner;Neena Singh;Curtis Tatsuoka;Brian Appleby;Xiongwei Zhu;Rong Xu;Vahram Haroutunian;Wen-Quan Zou;Jiyan Ma;Shu G. Chen;
Journal acta neuropathologica communications
Year 2021
DOI
10.1186/s40478-021-01175-w
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.